A domestic biopharmaceutical company is accused of disbanding its oncology sales team, suspected to be Maiwei Bio. The company has stated that they will not respond.

On November 13th, it was reported that a domestic biopharmaceutical company disbanded its tumor sales team, with information pointing to Maiwei Biotech. In response, a reporter from Jiemian News called Maiwei Biotech's secretary's office/public phone number, and the person who answered the phone said that the company did not disband the tumor sales team, but also did not inform the reporter of the current number of team members. They only stated that the company has statistics on the number of research and development personnel, which are disclosed in the financial report. Subsequently, when the reporter contacted Maiwei Biotech again, the company stated that they would not respond to this matter.